Pharmacokinetic analysis of topotecan after intra-vitreal injection: implications for retinoblastoma treatment | ||
| dc.conicet.fuente | unificacion | |
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Farmacología | |
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Farmacología | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan" | |
| dc.conicet.organizacion | Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan" | |
| dc.conicet.organizacion | Memorial Sloan-Kettering Cancer Center | |
| dc.conicet.organizacion | Memorial Sloan-Kettering Cancer Center | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan" | |
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Farmacología | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Estados Unidos | |
| dc.conicet.paisOrganizacion | Estados Unidos | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.produccionid | 9566287 | |
| dc.contributor.author | Buitrago, Emiliano | |
| dc.contributor.author | Höcht, Christian | |
| dc.contributor.author | Chantada, Guillermo Luis | |
| dc.contributor.author | Fandiño, Adriana Cristina | |
| dc.contributor.author | Navo, Elliot | |
| dc.contributor.author | Abramson, David H. | |
| dc.contributor.author | Schaiquevich, Paula Susana | |
| dc.contributor.author | Bramuglia, Guillermo Federico | |
| dc.date.accessioned | 2023-03-16T13:02:09Z | |
| dc.date.available | 2023-03-16T13:02:09Z | |
| dc.date.issued | 2010-07 | |
| dc.date.updated | 2023-03-15T10:05:16Z | |
| dc.description.abstract | Topotecan is a promising drug with activity against retinoblastoma, however, attaining therapeutic concentrations in the vitreous humor is still a challenge for the treatment of vitreous seeds in retinoblastoma. Our aim was to characterize topotecan pharmacokinetics in vitreous and aqueous humor, and to assess the systemic exposure after intra-vitreal injection in rabbits as an alternative route for maximizing local drug exposure. Anesthetized rabbits were administered intra-vitreal injections of 5 μg of topotecan. Vitreous, aqueous, and blood samples were collected at pre-defined time points. A validated high-performance liquid chromatography assay was used to quantitate topotecan (lactone and carboxylate) concentrations. Topotecan pharmacokinetic parameters were determined in vitreous, aqueous and plasma using a compartmental analysis.Topotecan lactone concentrations in the vitreous of the injected eye were about 8 ng/mL 48 h after drug administration. The median maximum vitreous, aqueous and plasma total topotecan concentrations (Cmax) were 5.3, 0.68 and 0.21 μg/mL, respectively. The Cmax vitreous/aqueous of treated eyes and the Cmax vitreous/plasma were approximately 8 and 254, respectively. Total topotecan exposure (AUC) in the vitreous of the injected eye was 50 times greater than the total systemic exposure. These findings suggest that intra-vitreal administration of only 5 μg of topotecan reaches significant local levels over an extended period of time while minimizing systemic exposure in the rabbit. Intra-vitreal topotecan administration offers a promising alternative route for enhanced drug exposure in the vitreous humor with potential application for treatment of vitreal seeds in retinoblastoma while avoiding systemic toxicities. | es |
| dc.description.fil | Fil: Buitrago, Emiliano. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Farmacología; Argentina | |
| dc.description.fil | Fil: Höcht, Christian. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Farmacología; Argentina | |
| dc.description.fil | Fil: Chantada, Guillermo Luis. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina | |
| dc.description.fil | Fil: Fandiño, Adriana Cristina. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina | |
| dc.description.fil | Fil: Navo, Elliot. Memorial Sloan-Kettering Cancer Center; Estados Unidos | |
| dc.description.fil | Fil: Abramson, David H.. Memorial Sloan-Kettering Cancer Center; Estados Unidos | |
| dc.description.fil | Fil: Schaiquevich, Paula Susana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina | |
| dc.description.fil | Fil: Bramuglia, Guillermo Federico. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Farmacología; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Buitrago, Emiliano; Höcht, Christian; Chantada, Guillermo Luis; Fandiño, Adriana Cristina; Navo, Elliot; et al.; Pharmacokinetic analysis of topotecan after intra-vitreal injection: implications for retinoblastoma treatment; Academic Press Ltd - Elsevier Science Ltd; Experimental Eye Research; 91; 1; 7-2010; 9-14 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 0014-4835 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/190746 | |
| dc.journal.ciudad | Amsterdam | es |
| dc.journal.number | 1 | es |
| dc.journal.pagination | 9-14 | es |
| dc.journal.pais | Países Bajos | es |
| dc.journal.title | Experimental Eye Research | es |
| dc.journal.volume | 91 | es |
| dc.language.iso | eng | es |
| dc.publisher | Academic Press Ltd - Elsevier Science Ltd | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://linkinghub.elsevier.com/retrieve/pii/S0014483510000849 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.exer.2010.03.009 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | RETINOBLASTOMA | es |
| dc.subject | TOPOTECAN | es |
| dc.subject | PHARMACOKINETICS | es |
| dc.subject.classification | Farmacología y Farmacia | es |
| dc.subject.classification | Medicina Básica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Pharmacokinetic analysis of topotecan after intra-vitreal injection: implications for retinoblastoma treatment | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.fc073cac-e135-4a55-a6f1-cae640687e43_E.pdf
- Tamaño:
- 242.78 KB
- Formato:
- Adobe Portable Document Format